COVID-19 Considerations for Basic and Translational Research

 View Only
last person joined: one year ago 

This discussion board is devoted to conversations directly relevant to research. Example topics include:
• Sample/tissue collection
• Model/reagent development
• Highlighting emerging literature
• Data sharing/opportunities for collaboration
• Pre-clinical observations
• Translational insights
• Research hypotheses
  • 1.  Shared Resources

    Posted 05-19-2020 08:33
    The purpose of this discussion thread is to share resources such as journal articles, protocols, and institutional experiences that may be of interest and value to the I-O community during the COVID-19 pandemic. When sharing a resource, simply reply to this post and include a brief description as well as the relevant web link or attached document (or both!). Documents shared in this discussion thread will be archived and freely available to viewers in the COVID-19 Considerations for Basic and Translational Research discussion board library.

    ------------------------------
    SITC Education
    Society for Immunotherapy of Cancer (SITC)
    Milwaukee WI
    ------------------------------


  • 2.  RE: Shared Resources

    Posted 05-19-2020 08:34
    SITC Additional COVID-19 Resources Page

    SITC has compiled a curated list of resources for immuno-oncology professionals to assist them in quickly and easily accessing the rapidly changing information during the COVID-19 pandemic. Sourced from validated external organizations and government agencies, the resources provide general guidance for both clinicians and researchers as well as information on specific concerns for a number of disease settings. Access these additional COVID-19 resources here:

    https://www.sitcancer.org/research/covid-19-resources/additionalresources

    ------------------------------
    SITC Education
    Society for Immunotherapy of Cancer (SITC)
    Milwaukee WI
    ------------------------------



  • 3.  RE: Shared Resources

    Posted 06-11-2020 16:37

    The National Cancer Institute (NCI) has released two Request for Applications (RFAs) for components of the new Serological Sciences Network (SeroNet). The two RFAs are for U01 Research Projects in SARS-CoV-2 Serological Sciences and U54 SARS-CoV-2 Serological Sciences Centers of Excellence. The deadline for applications is July 22, 2020, with awards anticipated to be announced in late September. 

    The scope of research supported will include:

    • Novel assays and model systems to test adaptive and immune response to SARS-CoV-2; 
    • Understanding the mechanism underlying innate, cell-mediated, and humoral immune response to SARS-CoV-2; 
    • Understanding the factors affecting the SARS-CoV-2 immune response and pathogenesis; and 
    • Defining access, communication, and implementation barriers related to SARS-CoV-2 serological testing.

    For those interested, NCI will be hosting a pre-application webinar on June 18th from 1:00-2:30 p.m. that will introduce the multiple components of SeroNet and answer questions about these RFAs. More information about the webinar and registration details can be found in an upcoming notice (NOT-CA-20-074) and on NCI's Serological Sciences Network for COVID-19 webpage.


    Resource posted on behalf of the National Cancer Institute

    ------------------------------
    SITC Education
    Society for Immunotherapy of Cancer (SITC)
    Milwaukee WI
    ------------------------------